MRSA, staphylococcal scalded skin syndrome, and other cutaneous bacterial emergencies

Pediatric Annals

Volumn 39, Issue 10, 2010, Pages 627-633

  Berk, David R ^a   Bayliss, Susan J ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PANTON VALENTINE LEUKOCIDIN; PETROLATUM; TOXIC SHOCK SYNDROME TOXIN 1;

ABDOMINAL DISEASE; BACTERIAL SKIN DISEASE; DIFFERENTIAL DIAGNOSIS; EMERGENCY; FEVER; HUMAN; IMPETIGO BULLOSA; MENSTRUATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYALGIA; NONHUMAN; PROGNOSIS; REVIEW; RISK FACTOR; SCARLET FEVER; SKIN CARE; SKIN INJURY; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; TOXIC EPIDERMAL NECROLYSIS; TOXIC SHOCK SYNDROME; VAGINITIS;

ABSCESS; CHILD; DIAGNOSIS, DIFFERENTIAL; EMERGENCIES; HUMANS; IMPETIGO; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTORS; SCARLET FEVER; SHOCK, SEPTIC; SKIN DISEASES, VESICULOBULLOUS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SCALDED SKIN SYNDROME;

EID: 78650200783     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20100922-02     Document Type: Review

References (40)

1. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners. Am J Clin Dermatol. 2007;8(5):259-270. (Pubitemid 47533552)
2. Elston DM.Community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Dermatol. 2007;56(1):1-16; quiz 17-20.
3. Kil EH, Heymann WR, Weinberg JM. Methicillin-resistant Staphylococcus aureus: an update for the dermatologist, Part 1: Epidemiology. Cutis. 2008;81(3):227-233.
4. Gorwitz RJ. A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J. 2008;27(1):1-7.
5. Groner A, Laing-Grayman D, Silverberg NB. Outpatient pediatric community-acquired methicillin-resistant Staphylococcus aureus: a polymorphous clinical disease. Cutis. 2008;81(2):115-122.
6. Kil EH, Heymann WR, Weinberg JM. Methicillin-resistant Staphylococcus aureus: an update for the dermatologist, Part 2: Pathogenesis and cutaneous manifestations. Cutis. 2008;81(3):247-254.
7. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin- susceptible S. aureus infection: a prospective investigation. Clin Infect Dis. 2007;44(4):471-482.
8. Inglis B, Matthews PR, Stewart PR. The expression in Staphylococcus aureus of cloned DNA encoding methicillin resistance. J Gen Microbiol. 1988;134(6):1465-1469.
9. Hamilton SM, Bryant AE, Carroll KC, et al. In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections. Clin Infect Dis. 2007;45(12):1550-1558.
10. Elston DM. Practical management tips for methicillin-resistant Staphylococcus aureus. Cutis. 2008;81(4):311-313.
11. Kil EH, Heymann WR, Weinberg JM. Methicillin-resistant Staphylococcus aureus: an update for the dermatologist, Part 3: Clinical management. Cutis. 2008;81(4):327-335.
12. Kluytmans J, van Belkum A, Verbrugh H.Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505-520.
13. Ladhani S, Evans RW. Staphylococcal scalded skin syndrome. Arch Dis Child. 1998;78(1):85-88.
14. Chang P, Mukundan D. Picture of the month. Staphylococcal scalded skin syndrome. Arch Pediatr Adolesc Med. 2008;162(12):1189-1190.
15. Sladden MJ, Mortimer NJ, Elston G, Newey M, Harman KE. Staphylococcal scalded skin syndrome as a complication of septic arthritis. Clin Exp Dermatol. 2007;32(6):754-755. (Pubitemid 47609744)
16. El Helali N, Carbonne A, Naas T, Kerneis S, Fresco O, Giovangrandi Y, Fortineau N, Nordmann P, Astagneau P. Nosocomial outbreak of staphylococcal scalded skin syndrome in neonates: epidemiological investigation and control. J Hosp Infect. 2005;61(2):130-138. (Pubitemid 41283337)
17. Yamasaki O, Yamaguchi T, Sugai M, Chapuis-Cellier C, Arnaud F, Vandenesch F, Etienne J, Lina G. Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins. J Clin Microbiol. 2005;43(4):1890-183. (Pubitemid 40491237)
18. Nishifuji K, Sugai M, Amagai M. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci. 2008;49(1):21-31.
19. Gentilhomme E, Faure M, Piemont Y, Binder P, Thivolet J. Action of staphylococcal exfoliative toxins on epidermal cell cultures and organotypic skin. J Dermatol. 1990;17(9):526-532. (Pubitemid 20382367)
20. Ladhani S, Joannou CL. Difficulties in diagnosis and management of the staphylococcal scalded skin syndrome. Pediatr Infect Dis J. 2000;19(9):819-821.
21. Patel GK, Finlay AY. Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol. 2003;4(3):165-175. (Pubitemid 36390473)
22. Cribier B, Piemont Y, Grosshans E. Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case. J Am Acad Dermatol. 1994;30(2 Pt 2):319-324. (Pubitemid 24045496)
23. Darmstadt GL, Lane AT. Impetigo: an overview. Pediatr Dermatol. 1994;11(4):293-303.
24. Geria AN, Schwartz RA. Impetigo update: new challenges in the era of methicillin resistance. Cutis. 2010;85(2):65-70.
25. Shands KN, Schmid GP, Dan BB, et al. Toxicshock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980;303(25):1436-1442.
26. Reingold AL, Hargrett NT, Dan BB, Shands KN, Strickland BY, Broome CV. Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med. 1982;96(6 Pt 2):871-874. (Pubitemid 12088886)
27. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol. 2001;55:77-104. (Pubitemid 32978101)
28. Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980;303(25):1429-1435.
29. Tofte RW, Williams DN. Toxic shock syndrome. Evidence of a broad clinical spectrum. JAMA. 1981;246(19):2163-2167. (Pubitemid 11030556)
30. Chesney PJ, Davis JP, Purdy WK, Wand PJ, Chesney RW. Clinical manifestations of toxic shock syndrome. JAMA. 1981;246(7):741-748. (Pubitemid 11044324)
31. The Working Group on Severe Streptococcal Infections.Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA. 1993;269(3):390-391.
32. Wolf JE, Rabinowitz LG. Streptococcal toxic shock-like syndrome. Arch Dermatol. 1995;131(1):73-77.
33. Stevens DL. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med. 2000;51:271-288. (Pubitemid 30216037)
34. Wilson GJ, Talkington DF, Gruber W, Edwards K, Dermody TS. Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. Clin Infect Dis. 1995;20(5):1333-1338.
35. Lesko SM, O'Brien KL, Schwartz B, Vezina R, Mitchell AA. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics. 2001;107(5):1108-1115. (Pubitemid 32440619)
36. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13(3):470-511.
37. Yang SG, Dong HJ, Li FR, et al. Report and analysis of a scarlet fever outbreak among adults through food-borne transmission in China. J Infect. 2007;55(5):419-424.
38. Manders SM. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol. 1998;39(3):383-398.
39. Bialecki C, Feder HM Jr, Grant-Kels JM. The six classic childhood exanthems: a review and update. J Am Acad Dermatol. 1989;21(5 Pt 1):891-903. (Pubitemid 19268631)
40. Quinn RW. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever. Rev Infect Dis. 1989;11(6):928-953.